CD4 and melanoma: More recently, transcriptomic comparison of CD4+ T cells at baseline and antigen specific CD4+ T cells after neoantigen vaccination in melanoma patients revealed significant induction of effector and memory T cell gene expression programs including Tbx21 [26].